Global Health Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	41,824	36,923	32,751	27,099	21,673	14,467
Other Revenue	-	-	-	-	51.68	51.68
Revenue	41,824	36,923	32,751	27,099	21,725	14,519
Revenue Growth (YoY)	17.16%	12.74%	20.86%	24.74%	49.63%	-4.37%
Cost of Revenue	20,523	17,771	15,584	13,344	11,667	8,589
Gross Profit	21,301	19,152	17,167	13,755	10,057	5,930
Selling, General & Admin	7,037	5,984	5,199	4,213	2,920	388.82
Other Operating Expenses	4,842	3,975	3,757	3,123	2,461	3,472
Operating Expenses	14,358	12,322	10,884	8,911	6,711	5,146
Operating Income	6,943	6,829	6,283	4,844	3,346	784.68
Interest Expense	-662.01	-640.24	-725.39	-774.64	-789.56	-671.02
Interest & Investment Income	703.18	703.18	596.78	355.36	167.22	177.59
Currency Exchange Gain (Loss)	3.7	3.7	-19.19	-44.36	13.62	-20.81
Other Non Operating Income (Expenses)	85.46	27.48	31.08	20.21	41.6	36.82
EBT Excluding Unusual Items	7,073	6,924	6,166	4,400	2,779	307.26
Merger & Restructuring Charges	-339.11	-498.96	-	-	-	-
Gain (Loss) on Sale of Assets	2.19	2.19	8.2	-6.77	2.94	8.63
Asset Writedown	-	-	-	-	-	-12.58
Other Unusual Items	-124.29	45.77	96.84	99.41	23.38	21.35
Pretax Income	6,612	6,473	6,271	4,493	2,806	324.66
Income Tax Expense	1,474	1,659	1,490	1,232	843.59	36.58
Earnings From Continuing Operations	5,138	4,813	4,781	3,261	1,962	288.07
Minority Interest in Earnings	0.79	1.19	1.34	-	-	-
Net Income	5,139	4,814	4,782	3,261	1,962	288.07
Net Income to Common	5,139	4,814	4,782	3,261	1,962	288.07
Net Income Growth	1.27%	0.68%	46.65%	66.20%	581.07%	-20.70%
Shares Outstanding (Basic)	269	269	269	259	252	251
Shares Outstanding (Diluted)	269	269	269	259	252	252
Shares Change (YoY)	0.03%	-	3.52%	2.81%	0.13%	0.20%
EPS (Basic)	19.13	17.92	17.80	12.58	7.78	1.15
EPS (Diluted)	19.10	17.92	17.80	12.57	7.77	1.14
EPS Growth	1.24%	0.67%	41.61%	61.78%	581.58%	-20.83%
Free Cash Flow	-	1,072	3,335	4,085	367.87	960.32
Free Cash Flow Per Share	-	3.99	12.42	15.74	1.46	3.81
Dividend Per Share	-	0.500	-	-	-	-
Gross Margin	50.93%	51.87%	52.42%	50.76%	46.29%	40.84%
Operating Margin	16.60%	18.50%	19.18%	17.87%	15.40%	5.40%
Profit Margin	12.29%	13.04%	14.60%	12.03%	9.03%	1.98%
Free Cash Flow Margin	-	2.90%	10.18%	15.08%	1.69%	6.61%
EBITDA	8,788	8,531	7,793	6,188	4,483	1,843
EBITDA Margin	21.01%	23.11%	23.80%	22.83%	20.63%	12.70%
D&A For EBITDA	1,845	1,702	1,511	1,344	1,136	1,058
EBIT	6,943	6,829	6,283	4,844	3,346	784.68
EBIT Margin	16.60%	18.50%	19.18%	17.87%	15.40%	5.40%
Effective Tax Rate	22.29%	25.64%	23.77%	27.42%	30.07%	11.27%
Revenue as Reported	42,672	37,714	33,498	27,592	22,058	14,782
Advertising Expenses	-	-	-	249.07	31.18	23.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.